VeriMomhypericum perforatum leaf extract é seguro durante a gravidez?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
Pregnancy-safe products containing hypericum perforatum leaf extract
Related ingredients
Frequently asked questions
- hypericum perforatum leaf extract é seguro durante a gravidez?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS or CIR reproductive prohibition for Hypericum perforatum leaf extract used topically; peer-reviewed data do not demonstrate confirmed teratogenicity from topical cosmetic use. Dermal exposure from cosmetics can produce low but measurable systemic exposure for botanical extracts, so exposure during pregnancy is scored as low but measurable (e=1). Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (limited/no conclusive reproductive hazard data).
- hypericum perforatum leaf extract é seguro durante a amamentação?
- No regulatory harmonised reproductive/breastfeeding classification. While oral St. John's wort is known for systemic drug interactions and there are reports of transfer with systemic use, topical cosmetic use of the leaf extract is not established to cause significant transfer into breastmilk; therefore hazard and mechanism are scored 0 and exposure is low but measurable (e=1). Sources: PubMed (systemic use literature), CosIng, ECHA (no harmonised CLP).
- hypericum perforatum leaf extract é seguro para a pele do bebê?
- No evidence of a reproductive or developmental hazard specific to infants from topical exposure to Hypericum perforatum leaf extract; mechanism of reproductive toxicity is not demonstrated. Because infants (0–3 yr) have an immature skin barrier and higher surface-area-to-weight, dermal exposure is increased relative to adults, so exposure is increased to moderate (adult e=1 → infant e=2). Note: phototoxic constituents (e.g., hypericin) may increase skin reaction risk but that is separate from reproductive classification. Sources: CosIng, PubMed (phototoxicity literature), ECHA (no harmonised CLP).
- Como o VeriMom pontua hypericum perforatum leaf extract?
- O VeriMom pontua hypericum perforatum leaf extract em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a hypericum perforatum leaf extract na gravidez?
- Veja nossa lista curada de alternativas seguras a hypericum perforatum leaf extract com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.